← Back to Discover
Caligan Partners LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,125,706,950
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- LIQUIDIA CORPORATION · COM NEW · 53635D202 · shares: $647,319,259
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $367,404,968
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $207,608,952
- VAXCYTE INC · COM · 92243G108 · shares: $127,225,411
- EXELIXIS INC · COM · 30161Q104 · shares: $84,512,985
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $78,153,220
- AVALO THERAPEUTICS INC · COM NEW · 05338F306 · shares: $58,468,244
- XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $53,717,020
- ADMA BIOLOGICS INC · COM · 000899104 · shares: $47,918,309
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares · CALL: $47,157,104
Reported holdings
28 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | — | 8,118,892 shares | $647,319,259 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 1,961,795 shares | $367,404,968 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 1,557,924 shares | $207,608,952 |
| VAXCYTE INC | COM | 92243G108 | — | 2,188,636 shares | $127,225,411 |
| EXELIXIS INC | COM | 30161Q104 | — | 1,553,262 shares | $84,512,985 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 2,500,103 shares | $78,153,220 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 3,163,866 shares | $58,468,244 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 889,944 shares | $53,717,020 |
| ADMA BIOLOGICS INC | COM | 000899104 | — | 5,725,007 shares | $47,918,309 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | CALL | 251,800 shares | $47,157,104 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 1,438,070 shares | $46,672,562 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 1,381,317 shares | $43,856,815 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 2,193,981 shares | $40,303,431 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 1,925,066 shares | $35,440,465 |
| SAB BIOTHERAPEUTICS INC | COM NEW | 78397T202 | — | 7,967,207 shares | $31,072,107 |
| INVENTIVA SA | ADS | 46124U107 | — | 8,163,191 shares | $30,856,862 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 4,298,248 shares | $30,517,561 |
| TYRA BIOSCIENCES INC | COM | 90240B106 | — | 806,986 shares | $25,775,133 |
| OPUS GENETICS INC | COM | 67577R102 | — | 6,077,084 shares | $24,976,815 |
| ANIKA THERAPEUTICS INC | COM | 035255108 | — | 1,435,130 shares | $20,995,952 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 2,500,000 shares | $19,325,000 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 1,736,111 shares | $16,840,277 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 629,467 shares | $15,736,675 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 200,000 shares | $11,040,000 |
| VERRICA PHARMACEUTICALS INC | COM SHS | 92511W207 | — | 923,910 shares | $5,654,329 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | CALL | 90,000 shares | $3,339,900 |
| ADMA BIOLOGICS INC | COM | 000899104 | CALL | 300,000 shares | $2,511,000 |
| CELLECTAR BIOSCIENCES INC | COM NEW | 15117F880 | — | 469,998 shares | $1,306,594 |